Product Images Pregabalin
View Photos of Packaging, Labels & Appearance
- 681-30 - PREGABALIN 60760 681 30
- pregabalin-equation - pregabalin equation
- pregabalin-fig-a - pregabalin fig a
- pregabalin-Figure-6 - pregabalin figure 6
- pregabalin-Figure-7 - pregabalin figure 7
- Study DPN 1 - pregabalin image 1
- Study SCI 1 - pregabalin image 10
- Pain Intensity-study SCI 2 - pregabalin image 11
- Study DPN 2 - pregabalin image 2
- Study PHN 1 - pregabalin image 3
- Study PHN 2 - pregabalin image 4
- Study PHN 3 - pregabalin image 5
- Fibromyalgia Study F1 - pregabalin image 8
- Fibromyalgia Study F2 - pregabalin image 9
- Pregabalin structure - pregabalin srtuc 1
Product Label Images
The following 15 images provide visual information about the product associated with Pregabalin NDC 60760-681 by St. Mary's Medical Park Pharmacy, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
681-30 - PREGABALIN 60760 681 30
This text appears to be a label for Pregabalin capsules, each containing 100mg of the active ingredient. The label includes details like NDC, lot numbers, expiration dates, and usage instructions to be followed. The product is packaged in a controlled room temperature environment. The manufacturing information indicates a location in Mumbai, India.*
pregabalin-equation - pregabalin equation
This is not available as the text is a mathematical formula and not a meaningful description.*
pregabalin-fig-a - pregabalin fig a
This text provides information on Responder Rate (%) with different dosage levels. It includes percentages such as 201%, placebo, and dosages like 2.5 and 10 mg/kg/day.*
pregabalin-Figure-6 - pregabalin figure 6
This text likely contains data from different studies comparing the effects of different dosages of a medication on a particular outcome, likely with a placebo group for comparison. The data shows percentages and statistical significance of the different dosages compared to the placebo group.*
pregabalin-Figure-7 - pregabalin figure 7
Study DPN 1 - pregabalin image 1
Study SCI 1 - pregabalin image 10
Pain Intensity-study SCI 2 - pregabalin image 11
Study DPN 2 - pregabalin image 2
Study PHN 1 - pregabalin image 3
Study PHN 2 - pregabalin image 4
This text mentions the improvement in patients, with reference to the use of pregabalin at different dosages and placebo. It also indicates a percentage of improvement in pain from the baseline.*
Study PHN 3 - pregabalin image 5
This text provides information on the percentage of patients who improved with different treatments. It mentions Pregatalin taken multiple times a day and a placebo. The data seems to be related to the improvement in pain from a baseline.*
Fibromyalgia Study F1 - pregabalin image 8
This text provides information on the percentage of patients improved with different doses of Pregabalin. It includes data for Pregabalin doses of 50mg, 450mg, and 300mg daily. Additionally, it presents the percentage of improvement in pain from baseline.*
Fibromyalgia Study F2 - pregabalin image 9
Pregabalin structure - pregabalin srtuc 1
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
